Strengthening the Mitochondrial Biology Research Platform Through the Acquisition of Nanna Therapeutics
A standalone acquisition to make UK-based Nanna Therapeutics a wholly owned subsidiary and strengthen the drug discovery research platform by incorporating its research expertise and technological capabilities in mitochondrial biology.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.